CinnaGen Co. was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology and related fields. Since its start of operation was by the effort of 4 scientists, CinnaGen has grown to become the biggest bio-pharmaceutical manufacturer and biotech exporter in the region.
We aim at developing Biosimilar products for immunological diseases, infertility, hormonal disorders, and cancer, and also presenting research and development services. The company currently allocates 20% of its total turnover to research and development activities.
We aim at taking advantage of our expertise to identify the chosen products through collaborative strategies In order to promote the sustainable development of human health.
At present, Cinnagen has manufactured a range of specialty pharmaceutical biotechnology products, and in 1995 it prevented any foreign currency drain (About 585 million dollar) for buying these medicines. Which contributes to the country's economy and the purchasing power of domestic patients. Acquisition of two statues and two certificates of observing consumers’ rights from the Ministry of Industry, Mining and Trade of Iran during the years 2011-2014 confirmed this point.